Parnassus Investments Has Trimmed By $7.00 Million Its Cvs Health Corp. (CVS) Position; Merlin Entertainments plc (LON:MERL) Had 14 Analysts Last Week

May 23, 2018 - By Vivian Park

CVS Health Corporation (NYSE:CVS) Logo

Among 19 analysts covering Merlin Entertainments PLC (LON:MERL), 14 have Buy rating, 0 Sell and 5 Hold. Therefore 74% are positive. Merlin Entertainments PLC had 194 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by Peel Hunt on Friday, April 27 with “Buy”. Liberum Capital maintained the shares of MERL in report on Friday, May 4 with “Hold” rating. The firm earned “Buy” rating on Wednesday, October 7 by Nomura. The rating was maintained by JP Morgan with “Neutral” on Monday, February 20. The rating was maintained by Shore Capital with “Hold” on Thursday, March 2. The stock of Merlin Entertainments plc (LON:MERL) earned “Hold” rating by Berenberg on Friday, March 2. As per Tuesday, November 3, the company rating was maintained by Barclays Capital. The stock of Merlin Entertainments plc (LON:MERL) earned “Hold” rating by Kepler Cheuvreux on Friday, July 29. Barclays Capital maintained Merlin Entertainments plc (LON:MERL) on Thursday, January 11 with “Overweight” rating. The stock of Merlin Entertainments plc (LON:MERL) earned “Neutral” rating by JP Morgan on Tuesday, March 28. See Merlin Entertainments plc (LON:MERL) latest ratings:

17/05/2018 Broker: Barclays Capital Rating: Overweight New Target: GBX 400.00 Maintain
04/05/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 360.00 Maintain
27/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 375.00 New Target: GBX 375.00 Maintain
27/04/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 360.00 New Target: GBX 360.00 Maintain
06/04/2018 Broker: HSBC Rating: Buy Old Target: GBX 450.00 Maintain
29/03/2018 Broker: Barclays Capital Rating: Overweight Old Target: GBX 400.00 New Target: GBX 400.00 Maintain
22/03/2018 Broker: Barclays Capital Rating: Overweight Maintain
07/03/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 360.00 New Target: GBX 360.00 Maintain
06/03/2018 Broker: Credit Suisse Rating: Outperform Old Target: GBX 440.00 New Target: GBX 440.00 Maintain
02/03/2018 Broker: Credit Suisse Rating: Outperform Old Target: GBX 440.00 New Target: GBX 440.00 Maintain

Parnassus Investments decreased Cvs Health Corp. (CVS) stake by 1.33% reported in 2017Q4 SEC filing. Parnassus Investments sold 97,153 shares as Cvs Health Corp. (CVS)’s stock declined 17.45%. The Parnassus Investments holds 7.21 million shares with $522.95 million value, down from 7.31 million last quarter. Cvs Health Corp. now has $66.39B valuation. The stock decreased 0.49% or $0.32 during the last trading session, reaching $65.3. About 1.52M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 23, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

The stock decreased 1.45% or GBX 5.6 during the last trading session, reaching GBX 380.6. About 1.28 million shares traded. Merlin Entertainments plc (LON:MERL) has 0.00% since May 23, 2017 and is . It has underperformed by 11.55% the S&P500.

Merlin Entertainments plc operates visitor attraction places worldwide. The company has market cap of 3.88 billion GBP. The firm operates midway attractions under the Madame Tussauds, The Eye Brand, SEA LIFE, The Dungeons, LEGOLAND Discovery Centres, Seal Sanctuaries, Blackpool Tower, WILD LIFE, Australian Treetop Adventures, Hotham Alpine Resort, Falls Creek, and Shreks Adventure London brands. It has a 18.57 P/E ratio. It also operates LEGOLAND parks under the LEGOLAND Billund, LEGOLAND Windsor, LEGOLAND California, LEGOLAND Deutschland, LEGOLAND Florida, LEGOLAND Malaysia, LEGOLAND Dubai, and LEGOLAND Japan brands; and resort theme parks under the Alton Towers, Chessington World of Adventures, Gardaland, Heide Park, THORPE PARK Resort, and Warwick Castle brand names.

Since February 16, 2018, it had 2 insider purchases, and 1 sale for $713,454 activity. On Friday, May 4 the insider BROWN C DAVID II bought $619,900. $1.51 million worth of CVS Health Corporation (NYSE:CVS) was bought by DORMAN DAVID W. Shares for $1.42M were sold by Foulkes Helena on Friday, February 16.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It is negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Geode Mgmt Limited Liability holds 0.27% of its portfolio in CVS Health Corporation (NYSE:CVS) for 10.87M shares. Bradley Foster Sargent Ct invested in 25,712 shares. E&G Advsr LP reported 6,771 shares. 22,301 were accumulated by Addison. Sumitomo Mitsui Asset Mngmt Company Limited, a Japan-based fund reported 73,422 shares. Massachusetts Financial Services Co Ma invested 0.2% of its portfolio in CVS Health Corporation (NYSE:CVS). Ahl Prns Llp has 161,907 shares for 0.18% of their portfolio. Citizens & Northern invested 1.28% of its portfolio in CVS Health Corporation (NYSE:CVS). Dean Investment Assoc Ltd Limited Liability Company holds 0.91% or 81,893 shares. Highland Cap Ltd Limited Liability Company, a Tennessee-based fund reported 45,841 shares. Illinois-based Koshinski Asset Mngmt has invested 0.37% in CVS Health Corporation (NYSE:CVS). South Street Advsr Ltd stated it has 0.06% in CVS Health Corporation (NYSE:CVS). Columbia Asset Mngmt holds 0.14% or 6,846 shares in its portfolio. Moreover, Davis R M has 0.03% invested in CVS Health Corporation (NYSE:CVS) for 9,067 shares. The Pennsylvania-based Girard Limited has invested 0.58% in CVS Health Corporation (NYSE:CVS).

Parnassus Investments increased Mondelez International Inc. Class A (NASDAQ:MDLZ) stake by 47,505 shares to 11.70 million valued at $500.89 million in 2017Q4. It also upped Starbucks Corp. (NASDAQ:SBUX) stake by 18,399 shares and now owns 9.31 million shares. Expeditors International Of Washington Inc. (NASDAQ:EXPD) was raised too.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. Deutsche Bank maintained it with “Hold” rating and $121 target in Thursday, August 20 report. On Wednesday, October 18 the stock rating was maintained by Jefferies with “Hold”. The firm has “Outperform” rating given on Thursday, December 17 by Oppenheimer. The company was maintained on Tuesday, November 21 by Leerink Swann. The rating was maintained by Jefferies on Thursday, May 12 with “Buy”. The stock has “Hold” rating by Loop Capital on Tuesday, November 7. Robert W. Baird maintained the stock with “Hold” rating in Monday, September 25 report. The rating was upgraded by Raymond James to “Buy” on Thursday, January 4. The stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given on Monday, December 4 by Needham. Citigroup maintained CVS Health Corporation (NYSE:CVS) on Tuesday, February 13 with “Neutral” rating.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “We Are Playing The CVS Hand” on May 11, 2018, also Marketwatch.com with their article: “CVS-Aetna merger is not about the minute clinic, Aetna CEO says” published on May 22, 2018, Fool.com published: “5 Things You’ll Want to Know About CVS Health’s Plans for 2018 and Beyond” on May 04, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Seekingalpha.com and their article: “Trade Mistake 3: CVS Boredom Trade” published on May 09, 2018 as well as Seekingalpha.com‘s news article titled: “CVS Health: A Store-Level Look At The Proposed Healthcare Giant” with publication date: April 26, 2018.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on August, 14. They expect $1.61 earnings per share, up 21.05% or $0.28 from last year’s $1.33 per share. CVS’s profit will be $1.64B for 10.14 P/E if the $1.61 EPS becomes a reality. After $1.48 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 8.78% EPS growth.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Vivian Park

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: